At ASGCT meeting, Westlake and Versant-backed Kate Therapeutics shows its AAV gene therapy targets muscle, heart in primates
Product Development
Former FDA official concerned about unintended consequences of bringing agency into geopolitical competition
Politics, Policy & Law
Finance
Strong fundraising week also included launches by Prologue and Commit, plus raises by Aardvark, Memo and OverT
Management Tracks
With CEO Shao-Lee Lin leaving, the company said it’s aiming to preserve cash resources, with a series of decision-driving clinical catalysts on the way
Plus: New heads of commercial and strategy at AdvanCell, and an update from Vivodyne
BioCentury ISSN 1097-7201